Retail Analytics: Breaking Through the Hype and the Noise

In the latest podcast episode of “Point of Scale,” host James Prebil sat down and interviewed his friend and Ocean Spray’s Director of Category Insights and Analytics, Paul Sproles. The two discussed how analytics are a vital aspect in shaping retail and consumerism.  

Sproles said that having all the information in retail is the beacon to gathering and compiling analytics. He also added that every detail matters because it allows for less error and more accuracy in determining the ins-and-outs of your business. He described retail as “knowing everything about everything that has ever been done always.” 

Knowing your consumers is another major factor. Retail is such an important part of many peoples lives and because the world is so consumer and marketing–driven, knowing who the buyers are is a highly important aspect in that.   

Sproles iterated that consumers are the ones who make decisions that decide who gets hired or fired. That reason alone is why analytics in the retail industry  

“Retail analytics is the idea that we can solve what I would say is the unsolvable, which is anticipating the human experience through purchasing,” said Sproles.  

And what does this purchasing power show? Spoles mentioned that this fact is a principal area of what molds the retail industry. However, every solution can come with a challenge 

“Realize that every second there are hundreds and millions of people making decisions that we try to put analytics behind and we try to find data points to tell a story,” said Sproles. “It’s a beautiful artistic concept — it’s also very difficult to actually put in.” 

That challenge is usually in the form of data collecting because a lot of components go into collecting the data. Additionally, Spoles said that the data is useful to every person in a specific retail business, as it will be helpful to every employee from lower to high management. Not only that, analytics will also help with future projections in regards to weather and major events. 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More